xemilofiban has been researched along with Diabetes Mellitus, Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anders, RJ; Burns, DM; Cove, CS; DeFranco, AC; Ellis, SG; Kottke-Marchant, K; Lowrie, M; Miller, DP; Moliterno, DJ; Raymond, RE; Simpfendorfer, C; Sutton, JM; Topol, EJ | 1 |
1 trial(s) available for xemilofiban and Diabetes Mellitus, Type 1
Article | Year |
---|---|
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Benzamidines; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex | 1997 |